Patrys (PAB)

Shares / Stock Code

PAB

Stock Exchange / Sharemarket

Australian Securities Exchange

Patrys (PAB) is a company that focuses on the development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer. The company has the world-wide, exclusive rights to technologies developed over 25 collective years of research and development that allow the capture, development and production of natural human antibodies for potential therapeutic applications.

Several antibodies that form Patrys' deep product pipeline have been successfully trialled in animal models of human lung, pancreatic, gastric and colon cancers.Patrys has in place drug development collaborations with three large pharmaceutical companies. Company was on Australian stockmarket on 13 July, 2007.

In addition to its internal drug development projects and existing collaborations, Patrys has acquired Acceptys, Inc., an American company developing the platform natural human antibody technology for the treatment of infectious diseases including, Hepatitis C, Malaria and Staphylococcus A.

Patrys' commercial strategy is to progress the internal development of lead product candidates while drawing benefits from partnerships and collaborations aimed at developing other candidates in the company's deep product pipeline.The company has filed a broad range of patent applications to protect its antibodies, the antibody-producing cell lines, molecular targets and technologies.Its wholly-owned subsidiary is Patrys GmbH. On November 28, 2008, Patrys acquired Acceptys, Inc.

Patrys (PAB) Products and Services

  • Development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.

Patrys (PAB) Locations and Subsidiaries

Patrys Head Office
Suite 614, Level 6 Equitable House, 343 Little Collins Street,
MELBOURNE, VIC, AUSTRALIA, 3000
Phone: (03) 9670 3273
Fax: (03) 9670 3247

Patrys (PAB) Share Price

Submitted by ASX Listed Company on 18 May, 2010 - 01:02

Download our FREE App


Signup for Free
Don't miss out on your free share trading articles.


Free Risk Money Management Calculator for those who sign up!